Women’s attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review
Open Access
- 5 August 2022
- journal article
- review article
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 48 (4) , 295-306
Abstract
Objective To provide insights into women’s attitudes towards a human papillomavirus (HPV)-based cervical cancer screening strategy. Data sources Medline, Web of Science Core Collection, Cochrane Library, PsycINFO, CINAHL and ClinicalTrials.gov were systematically searched for published and ongoing studies (last search conducted in August 2021). Methods of study selection The search identified 3162 references. Qualitative and quantitative studies dealing with women’s attitudes towards, and acceptance of, an HPV-based cervical cancer screening strategy in Western healthcare systems were included. For data analysis, thematic analysis was used and synthesised findings were presented descriptively. Tabulation, integration, and results Twelve studies (including 9928 women) from USA, Canada, UK and Australia met the inclusion criteria. Women’s attitudes towards HPV-based screening strategies were mainly affected by the understanding of (i) the personal risk of an HPV infection, (ii) the implication of a positive finding and (iii) the overall screening purpose. Women who considered their personal risk of HPV to be low and women who feared negative implications of a positive finding were more likely to express negative attitudes, whereas positive attitudes were particularly expressed by women understanding the screening purpose. Overall acceptance of an HPV-based screening strategy ranged between 13% and 84%. Conclusion This systematic review provides insights into the attitudes towards HPV-based cervical cancer screening and its acceptability based on studies conducted with women from USA, Canada, UK and Australia. This knowledge is essential for the development of education and information strategies to support the implementation of HPV-based cervical cancer screening. Systematic review registration PROSPERO (CRD42020178957).Keywords
Funding Information
- Swiss Cancer Screening Committee (ZVK2019102803)
This publication has 38 references indexed in Scilit:
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014
- Human papillomavirus and cervical cancerThe Lancet, 2013
- Women's intentions to receive cervical cancer screening with primary human papillomavirus testingInternational Journal of Cancer, 2013
- Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancerJournal of Infection, 2013
- Recommendations on screening for cervical cancerCanadian Medical Association Journal, 2013
- The challenges of organising cervical screening programmes in the 15 old member states of the European UnionEuropean Journal of Cancer, 2009
- Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological StudiesCancer Epidemiology, Biomarkers & Prevention, 2009
- Methods for the thematic synthesis of qualitative research in systematic reviewsBMC Medical Research Methodology, 2008
- Prevalence of HPV Infection Among Females in the United StatesJAMA, 2007
- Social and psychological impact of HPV testing in cervical screening: a qualitative studySexually Transmitted Infections, 2006